FTO and pancreatic neoplasm: In pancreatic cancer cells, although FTO still inhibited the m6A modification of its target tissue factor pathway inhibitor-2 (TFPI2), unlike PD-L1, the mRNA expression of TFPI2 was decreased because less TFPI2 was bound by YTHDF139.